SPP Spring Meeting 2024
Baltimore, MD
Hyatt Regency Baltimore Inner Harbor
300 Light Street Baltimore, Maryland 21202

Conference Schedule

Connect to the Hyatt Complimentary Wifi, open a web browser, and accept the conditions with the log in button. 

Click the tabs below to see the schedule for each day.

  • 12:00pm – 8:00pm Registration Desk Open
  • 1:30pm – 4:00pm Executive Committee Meeting – Annapolis Room
  • 4:30pm – 6:30pm Board of Directors Meeting – Columbia Room
  • 6:30pm – 8:30pm Board of Directors Dinner — President’s Room (Invite Only)
  • 7:00am – 5:00pm Registration Desk Open
  • 7:00am – 8:00am Breakfast – Constellation CDEF
  • 7:00am – 9:00pm Poster Hall – Constellation CDEF

Constellation AB

  • 8:00am President’s Welcome Linda Ernst, MD Northshore University HealthSystem
  • 8:00am – 9:00am Platform Session I: Pediatric Malignancies
    • Clinicopathogenetic Heterogeneity of Lineage Switch in Pediatric Acute Leukemia – Xiayuan
      Liang, MD Children’s Hospital of Colorado
    • Recurrent SRF Gene Fusions and Biallelic TP53 Inactivation in Two Histologically Distinct
      Subsets of Pediatric Leiomyosarcoma of Soft Tissue – Erin Alston, MD Boston Children’s
      Hospital
    • Integrated Characterization of Soft Tissue and CNS CIC-Rearranged Sarcomas Reveals
      Shared Epigenetic Signatures Across Fusion Types and Anatomic Locations – John Van
      Arnam, MD, MS Texas Children’s Hospital
    • Thyroid cytology in pediatric thyroid nodules; comparing our institutional risk of malignancy
      to the 2023 Bethesda System for Reporting Thyroid Cytopathology (BSRTC): A 15 year
      institutional experience – Lame Balikani, MD, MPH Nationwide Children’s Hospital
  • 9:00am – 10:00am Platform Session II: Liver and Kidney Pathology
    • Molecular profiling in pediatric hepatocellular adenomas: does it help with the diagnosis
      and subtyping? – Yan Zhou Boston Children’s Hospital
    • Progressive Familial Intrahepatic Cholestasis Type 3 (PFIC3): Clinical, Molecular and
      Hepatic Findings in Children and Adolescents – Melissa Mejia Bautista, MD Boston
      Children’s Hospital
    • Histologic Porto-sinusoidal Vascular Disease is Frequent in Native Liver Biopsies of
      Children with Cystic Fibrosis – Elizabeth Taylor, MD Baylor College of Medicine
    • A Retrospective Review of Borderline T-Cell-Mediated Acute Rejection Cases in Pediatric
      Transplanted Kidneys Using the 2019 Banff Classification – Ryan Reagans, MD The Ohio
      State University Wexner Medical Center
  • 10:00am – 10:30am BREAK – Constellation CDEF
  • 10:30am – 11:30am Platform Session III: Lung and Perinatal Pathology
    • Histologic Correlates of Failed Lung Allografts in the Pediatric Population – Sam Gulino, MD
      Children’s National Hospital
    • Antibody-mediated Rejection in Pediatric Lung Transplantation: Unraveling
      Histopathological Insights – Mokhtar Hossam Moha Abdelhammed, MD Baylor College of
      Medicine
    • Placental pathology and umbilical cord blood gene expression – Linda Ernst, MD Endeavor
      Health
    • Pregnancy Loss Associated with COVID-19 infection: Correlations with viral RNA in
      placental and fetal tissue – Ansa Mehreen, MBBS Vanderbilt University Medical Center
  • 11:30am – 12:30pm Business Meeting (Boxed Lunches to be served)
  • 12:30pm – 1:00pm President’s Address
    • Linda Ernst, MD Northshore University HealthSystem
    • Cristina Pacheco, MD Seattle Children’s Hospital
  • 1:00pm – 1:30pm BREAK – Constellation CDEF 2
  • 1:30pm – 2:30pm Farber-Landing Lecture – Neuroblastoma Pathology: 40 Years of Experience
    • Hiroyuki Shimada, MD, PhD, FRCPA Stanford University Medical Center
  • 2:30pm – 4:05pm Symposium: Pediatric Thyroid Tumors: A Practical Update on The Classification, Molecular Diagnostics and Management Strategies
    • Course Directors: Huiying Wang, MD, Vanderbilt University Medical Center, and Vivian L. Weiss, MD, PhD, Vanderbilt University Medical Center
    • Radiologic features of pediatric thyroid nodules – what pathologists need to know – Jennifer Lim-Dunham, MD, Loyola University
    • Cytopathology of pediatric thyroid nodules – updates on new Bathesda system with emphasis on practical challenges and pitfalls Huiying Wang, MD, Vanderbilt University Medical Center
    • Pediatric thyroid nodules – molecular landscape and diagnosis Vivian L. Weiss, MD, PhD, Vanderbilt University Medical Center and Sule Canberk, MD, PHD University of Porto
  • 4:05pm – 4:35pm BREAK – Constellation CDEF
  • 4:35pm – 6:00pm Symposium: Pediatric Thyroid Tumors: A Practical Update on The Classification, Molecular Diagnostics and Management Strategies, continued
    • Pediatric thyroid tumors – updates on new WHO classification and emerging entities Zubair W. Baloch, MD, PhD, University of Pennsylvania Medical Center, Perelman School of Medicine
    • Management strategies for pediatric thyroid nodules – a pediatric otolaryngologist’s perspective Ryan Belcher, MD, MPH, Monroe Carell Jr. Children’s Hospital at Vanderbilt
    • Questions & panel discussion
  • 6:30pm – 7:45pm Poster Blitz
  • 7:45pm – 8:00pm Awards
  • 8:00pm – 9:00pm Cocktail Reception and Poster Hall – Constellation CDEF

Credit claiming:

To claim credit following the meeting, you will use SPP’s learning management system, EthosCE. To complete activity evaluations, claim CME credit, and download your Certificate of Credit or Certificate of Participation you must create an EthosCE account if you have not already.

  • Navigate to https://education.spponline.org/.
    • If you already have an EthosCE account:
      • Log in (please note: this is a different account than the one you use to access SPP’s main website).
      • When you log in, scroll down to the bottom of your profile, and the 2024 Spring Annual Meeting course will be located under the “My Current Courses” section.
      • Once you select the course, select “Take Course” and you will be prompted to complete the session and overall evaluations. Please be sure to only complete the evaluations when you are completely finished engaging with the activity. You may claim credit based on your attendance at either the live sessions or for watching the recorded sessions (Platform Presentations, Farber-Landing Lecture, and Symposium). However, you may not claim credit more than once for a given session.
    • If you do not yet have an EthosCE account:
      • Create your account under the same email address you used to register for the Spring Meeting.
      • When you log in, click “2024 Spring Annual Meeting” under ‘New Courses.’
      • Click ‘Register.’ Use the following codes to access:
        • Access code to enroll: “2024”
        • To check out: Use “SPRING2024” to remove associated cost and complete registration.
      • Select “Take Course” and you will be prompted to complete the session and overall evaluations. Please be sure to only complete the evaluations when you are completely finished engaging with the activity. You may claim credit based on your attendance at either the live sessions or for watching the recorded sessions (Platform Presentations, Farber-Landing Lecture, and Symposium). However, you may not claim credit more than once for a given session.
  • Upon completion of the evaluations, you will select the amount of credit you are claiming for the 2024 Spring Annual Meeting, and your certificate will be generated. Credit must be claimed by June 23, 2024.
    1.  
"

Faculty Bios

Hiroyuki Shimada

Hiroyuki Shimada

Dr. Hiroyuki Shimada is Professor of Pathology and of Pediatrics at Stanford University School of Medicine. Born in Tokyo, Japan, Dr. Shimada completed MD (1973) and PhD (1982) at Yokohama City University School of Medicine, Yokohama, Japan.  He went on to complete his pathology training at the Children’s Hospital (now the Nationwide Children’s Hospital) and Ohio State University, Columbus, Ohio, USA. Before moving to Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at University of Southern California Keck School of Medicine and working at Children’s Hospital Los Angeles.
      Dr. Shimada served as Chair of the International Neuroblastoma Pathology Committee (1999-2017) and is founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the Children’s Oncology Group (COG) Neuroblastoma Pathology Reference Laboratory since 2001, he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials.
      His contributions to the field have been recognized by numerous honors and awards, including The Lotte Straus Prize in 1989 and The Enid Gilbert-Barness Prize in 2018 – both from the Society for Pediatric Pathology, The Eleanor Humpherys Visiting Professorship at Department of Pathology, University of Chicago in 2005, an Honorary Fellowship from the Royal College of Pathologists of Australasia in 2012, the Lawrence G. Crowley Endowed Lectureship in Pediatrics at Stanford University in 2018. Recently he was presented with The Fred W. Stewart Award from the Memorial Sloan Kettering Cancer Center in 2022, and was also awarded The Presidential Distinguished Colleague Award from the Society for Pediatric Pathology and The Lifetime Achievement Award from the Advances in Neuroblastoma Research Association in 2023.
Huiying Wang

Huiying Wang

Dr. Huiying Wang obtained her MD degree from Anhui Medical University in China. After immigrating to the United States in 2000, she joined the cytotechnology training program at UCLA and California State University Dominguez Hills and graduated in 2003. From 2004 to 2011, she worked as a full-time cytotechnologist in Quest Diagnostics. Dr. Wang then completed the Anatomic Pathology and Clinical Pathology residency at SUNY Downstate Medical Center from in 2015, followed by a fellowship in Cytopathology at UCLA in 2016. She then joined the Department of Pathology, South California Permanente Medical Group from 2016 to 2017 as a staff cytopathologist. She went on to complete a second fellowship in Pediatric Pathology at Vanderbilt University Medical Center (VUMC) before becoming an Assistant Professor of Pathology, Microbiology and Immunology at Vanderbilt in 2018. She is board certified in Anatomic Pathology, Clinical Pathology, Cytopathology, and Pediatric Pathology. Her clinical responsibilities focus on pediatric pathology and cytopathology subspecialty services. Dr. Wang is currently the Program Director of the Pediatric Pathology Fellowship at VUMC. She is the lead pathologist on the Vanderbilt Pediatric Thyroid Nodule and Cancer Program.

Vivian Weiss

Vivian Weiss

Dr. Weiss is an Associate Professor and Associate Vice Chair for Clinical and Translational Research in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center. Dr. Weiss is board certified in Anatomic Pathology, Clinical Pathology, and Cytopathology. She has expertise in molecular pathology, cytopathology, and tumor immunology. She obtained her MD and PhD at Johns Hopkins and completed her residency and fellowship at Vanderbilt University Medical Center.

Dr. Weiss leads a federally funded research laboratory focused on the pathogenesis of pediatric and adult thyroid cancer. Thanks to initial funding from the ASC Shark Tank competition, Dr. Weiss’ laboratory has developed novel tools to advance our understanding of thyroid cancer (Vilgelm et al., iScience; Bechard et al., Nat Commun). She has also explored the molecular and immunologic drivers of thyroid cancer progression (Bergdorf et al., Endocrine-Related Cancer; Xu et al., Cell Genomics) and the drivers of pediatric thyroid carcinoma (Wang et al., Cancer Cytopathology; Ortega et al., JAMA Network Open; Gallant et al., JAMA Oncology, Ortega et al., in review).

Dr. Weiss is on the editorial board for three cytology journals. She co-directed two ASC educational workshops, The Molecular Cytopathology Workshop and the Cytology Research Workshop. She also is the former Chair of the Lab Services Committee of the ATA and former Chair for the Product Innovation Committee of the ASC.

 

Jennifer Lim-Dunham

Jennifer Lim-Dunham

Jennifer Lim-Dunham, MD, FACR, is a Professor of Radiology and Medical Education at Loyola University Medical Center and Stritch School of Medicine in Maywood, IL and a fellow of the American College of Radiology. She serves as Vice-Chair of Academic Affairs and Section Chief of Pediatric Radiology in the Department of Radiology, and Course Director of the Vertical Integrated Curriculum in Radiology in the medical school.  She is a past-president of the Chicago Radiologic Society and Illinois Radiological Society.  After graduating from Harvard College, she completed medical school and diagnostic radiology residency at the University of Chicago and fellowship in pediatric radiology at Northwestern University.

Dr. Lim-Dunham’s areas of clinical and academic expertise are pediatric thyroid ultrasound, pediatric ultrasound, and medical student education. She has published 39 peer-reviewed academic papers, three book chapters, and two invited commentaries, and twice edited the American College of Radiology Pediatric Radiology CPI Continuous Professional Improvement self-assessment module.

In 2018, Dr. Lim-Dunham and colleagues received the Radiology Walter E. Berdon Award for Best Clinical Research Paper appearing Pediatric Radiology in 2017 from the Society for Pediatric (Lim-Dunham JE, et al.  Ultrasound risk stratification for malignancy using the 2015 American Thyroid Association Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Pediatr Radiol  2017).  This paper was one of the first in the radiology literature addressing ultrasound risk stratification in thyroid nodules in children, and was followed by additional original research papers on this topic.  She has delivered multiple invited lectures at national and international academic meetings on imaging of pediatric thyroid nodules and served as invited participant in an expert panel and white paper committee on imaging of pediatric thyroid tumors convened by the Children’s Oncology Group and Society for Pediatric Radiology Oncology Committee.

Sule Canberk

Sule Canberk

Sule Canberk is a pathologist and cytopathologist, completed the PhD program in Molecular Pathology and Genetics at the University of Porto, Portugal. During the medical faculty education, she was visiting intern in the Department in Ludwig Maximilian University of Munich-Germany. This was followed by a residency in surgical pathology and a fellowship in Cytopathology. She has authored 67 peer-reviewed publications in leading pathology and cytopathology journals, and four book chapters; she has delivered numerous lectures, workshops and short courses at international meetings including ICC (International Cytology Congress), ECC (European Cytology Congress), AOTA (Asia and Oceania Thyroid Association), Porto Cancer meetings. She is dedicated to cytopathology and pathology of the thyroid in adult and pediatric populations and cytopathology of the lung. She had periods of observer ship in the University of Pennsylvania Cytopathology department in 2012 and 2013. She has served at the Acibadem University as an assistant professor since 2016 and currently, she is a member of a research group “Cancer signalling and metabolism” in IPATIMUP/İ3S, Porto, Portugal, mainly focused on “The genetic basis and phenotypic variation of oncocytic tumours in Thyroid”. During her PhD, she enhanced her expertise in pathology by completing a comprehensive series of courses at the European Bioinformatics Institute and acquiring skills in data analysis for transcriptomics and proteomics, She has been awarded two times by “Prof. E. Limbert of the Portuguese Society of Endocrinology, Diabetes and Metabolism (SPEDM) in 2018 (Possible interactions between BRAFV600E mutation and mTOR pathway in PTCs: potential consequences on tumour behaviour and response to therapy) and 2019 (diabetes mellitus and oncocytic thyroid: the mitochondrial connection). That same year, she secured a four-year grant from the FCT (Fundação para a Ciência e Tecnologia) for the project “Diabetes Mellitus and Oncocytic Tumors of Thyroid: The Mitochondrial Connection” (SFRH/BD/147650/2019).

 

Zubair Baloch

Zubair Baloch

Dr. Baloch received his medical degree from Liaquat Medical University in Hyderabad, Sind, Pakistan. After receiving his PhD in 1991 he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia under the mentorship of Dr. Prabodh K. Gupta (past president ASC). Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997 and is currently a professor of pathology and laboratory medicine there. He has authored more than 300 peer reviewed publications in leading pathology and Endocrine journals on the subject of endocrine and head and neck pathology; and book chapters and monographs. Dr. Baloch has delivered numerous lectures, workshops and short courses both at the national and international meetings including ASC, USCAP, ASCP, CAP, ECC, IAC and IAP. Dr. Baloch has coauthored 3 books and has served as co-editor of the most recent “Milan System for Reporting Salivary Gland Cytopathology”. Dr. Baloch has also served as the chair of the terminology and morphologic criteria committee of the 2007 NCI sponsored thyroid FNA initiative which led to the development of “Bethesda Thyroid FNA Classification Scheme”. Dr. Baloch also served on the international panel which recommended the renaming of encapsulated follicular variant of papillary thyroid carcinoma to non-invasive follicular tumor with papillary like nuclear features (NIFTP) and the current WHO editorial board of classification of thyroid neoplasms. Dr. Baloch is chief editor of Diagnostic Cytopathology and member of the editorial board of Cancer Cytopathology, Cytojournal, Endocrine Pathology and Journal of American Society of Cytopathology. Dr. Baloch has served as the chair of ASCP annual meeting scientific program committee (2014-2018), member of Papanicolaou Society scientific program committee, USCAP education committee, ASC executive board and chair of the annual meeting scientific program committee, ASCP committee for continuing professional development, American Association of Endocrinologist thyroid nodule guideline task force, USCAP executive board, American Thyroid Association laboratory test committee and well-differentiated thyroid carcinoma management guidelines committee. Dr. Baloch was recently inaugurated to be member of University of Pennsylvania Academy of Master Clinicians. Dr. Baloch’s awards include University of Pennsylvania Peter Nowell, Kevin Salhany and Best Graduate Student educator awards, ASCP President, Best educator and Arthur Purdy Stout lectureship award and ASC President’s service Award.

 

Ryan Belcher

Ryan Belcher

Ryan H. Belcher, M.D. M.P.H. is an associate professor at Monroe Carell Jr. Children’s Hospital at Vanderbilt. Due to his passion for global surgery, he obtained a Master’s in Public Health from the Vanderbilt School of Medicine with an emphasis in global health. Dr. Belcher helped develop and is the Surgical Co-Director of the Vanderbilt Pediatric Thyroid Nodule and Cancer Program as well as a member of the Vanderbilt Cleft and Craniofacial team. His clinical interests are pediatric thyroids, head and neck masses, craniofacial syndromes including cleft lip and palate, velopharyngeal dysfunction and speech outcomes, mandibular distraction, and global health related endeavors. He has published several book chapters and over 35 peer-reviewed journal articles in these clinical areas. His passion for global health has led to performing surgery internationally for cleft lip and palate among other craniofacial syndromes in Ethiopia, Kenya, Cameroon, Philippines, and Mexico. In 2021, Dr. Belcher was named by Nashville Business Journal to their annual 40 under 40 for young professionals in Nashville, TN who are making a difference in their business and community. Outside of work he enjoys spending time with his wife, Morgan, 1 year old daughter Lily, and their dog, Jolene. He is a Next Generation Board Member for a local healthcare non-profit, Siloam Health, which provides medical care to the local refugee and uninsured of central Tennessee.

Awards To Be Presented: 

  • Farber-Landing Lecture
  • Enid Gilbert Barness Prize
  • Lotte Strauss Prize
  • Young Investigator Research Grant
  • SPP Annual Research Grant
  • Best Paper
  • Presidential Distinguished Colleagues Awards

_________________________________________________________________________________________________________________________________________